Royal Bank of Canada »

Drugs Made In Amer Acq Ii shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Drugs Made In Amer Acq Ii shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Drugs Made In Amer Acq Ii

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acq Ii held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acq Ii by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $746k 75k 9.95

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Drugs Made In Amer Acq Ii

Magnetar Financial
MMCAP International Inc. SPC
Glazer Capital
LMR Partners
Healthcare Of Ontario Pension Plan Trust Fund
Millennium Management
Hudson Bay Capital Management
Vivaldi Asset Management
Tenor Capital Management
Polar Securities
CNH Partners
HGC Investment Management
Aristeia Capital
D. E. Shaw & Co
OMERS Administration Corporation

View all funds holding Drugs Made In Amer Acq Ii